![Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis](https://www.mdpi.com/cells/cells-08-00927/article_deploy/html/images/cells-08-00927-g001.png)
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
![CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610819301011-fx1.jpg)
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect
![The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife](https://iiif.elifesciences.org/lax/44245%2Felife-44245-fig8-v2.tif/full/1500,/0/default.jpg)
The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
![IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells](https://www.mdpi.com/ijms/ijms-22-11302/article_deploy/html/images/ijms-22-11302-g001.png)
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
![Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy](https://www.frontiersin.org/files/Articles/750478/fimmu-12-750478-HTML/image_m/fimmu-12-750478-g001.jpg)